Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join


Oct 24, 2021 9:00 AM - Oct 26, 2021 6:00 PM

(Tokyo Standard Time)

18th DIA Japan Annual Meeting 2021

LS03: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model?DCT & Remote Utilization (Part 1)

Session Chair(s)

Hiroshi  Matsuzawa, MSc

Hiroshi Matsuzawa, MSc

Clinical Development

Astellas Pharma Inc., Japan

Toshiharu  Sano, RPh

Toshiharu Sano, RPh

Associate Vice President, Japan Development Clinical Operation Area

MSD K.K., Japan


Ai  Nakamura

Ai Nakamura

Performance Working Group Member

R&D Head Club, Japan

Takeshi  Hashimoto, MPharm

Takeshi Hashimoto, MPharm


Novartis Pharma K.K., Japan

Masahito  Yamanaka

Masahito Yamanaka

Taskforce Member

EFPIA (Bayer Yakuhin, Ltd.), Japan

Junichi  Tanokashira

Junichi Tanokashira

Clinical Evaluation Expert Committee, Drug Evaluation Committee

Japan Pharmaceutical Manufacturers Association (JPMA), Japan

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.